CSR Draft Report Proposes New Panel To Review Clinical Oncology Research
In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease
Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says
In Congress: Gore, Democrats Rally For Anti-Tobacco Legislation
Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









